Document

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Stand-Alone Inducement Stock Option Grant of Alpine Immune Sciences, Inc. of our report dated March 23, 2023, with respect to the consolidated financial statements of Alpine Immune Sciences, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.